InsidersTradesSigma
Browse the full record of transactions filed by Sundaram Senthil Vel, 董事长兼首席执行官. Insider active across 1 company, notably Terns Pharmaceuticals, Inc.. Cumulatively, 1 disclosures have been logged. Split: 1 buy · 0 sell. Total volume traded: €10k. History available since 31 May 2022. The latest transaction was disclosed on 31 May 2022 (Acquisition). Regulator: SEC (Form 4). The full history is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
1 条申报中的 1 条
Senthil Vel Sundaram is the Chairman & CEO of Terns Pharmaceuticals, Inc. He is responsible for the strategic direction of the company and the management of its operations. Senthil brings expertise in business development and innovation to support the company's growth.